Physician profile
Brian Scott Planchard
NPI 1639377096
$2,446.70
in general payments reported to CMS, 2019-2025
21 companies · $458 in 2025
The $458 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2020: $519 · 2021: $357 · 2022: $171 · 2023: $250 · 2024: $167 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $875.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $412.66 | 2019-2025 | Rocklatan, Rhopressa, Hydrus Microstent |
| Kala Pharmaceuticals, INC. | $377.72 | 2020 | |
| Bausch & Lomb Americas INC. | $349.68 | 2024-2025 | Miebo, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $256.66 | 2019-2021 | |
| Horizon Therapeutics Plc | $150.51 | 2021-2022 | |
| Ivantis, INC | $126.14 | 2019 | |
| Glaukos Corporation | $105.99 | 2024-2025 | Idosetr, Idose |
| Sun Pharmaceutical Industries INC. | $99.32 | 2020-2021 | |
| Aerie Pharmaceuticals, INC. | $97.45 | 2019-2021 | |
| Coopervision INC. | $69.96 | 2023 | Myday Contact Lens |
| Abbvie INC. | $64.71 | 2023 | |
| Allergan, INC. | $60.95 | 2020-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $59.53 | 2022-2023 | Tecnis Iol |
| Dompe US, INC. | $52.78 | 2021-2022 | |
| Biotissue Holdings INC. | $43.83 | 2022-2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $41.22 | 2021-2023 | Omni Surgical System |
| Mallinckrodt Hospital Products INC. | $27.21 | 2024 | Acthar |
| Mallinckrodt Enterprises LLC | $19.47 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.99 | 2020 | |
| Genentech USA, INC. | $12.19 | 2022 | |
| New World Medical,INC. | $5.73 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Planchard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.